Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. / Frisch, Morten; Fenger, Claus; Van Den Brule, Adriaan J.C.; Sørensen, Per; Meijer, Chris J.L.M.; Walboomers, Jan M.M.; Adami, Hans Olov; Melbye, Mads; Glimelius, Bengt.
I: Cancer Research, Bind 59, Nr. 3, 01.02.1999, s. 753-757.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses
AU - Frisch, Morten
AU - Fenger, Claus
AU - Van Den Brule, Adriaan J.C.
AU - Sørensen, Per
AU - Meijer, Chris J.L.M.
AU - Walboomers, Jan M.M.
AU - Adami, Hans Olov
AU - Melbye, Mads
AU - Glimelius, Bengt
PY - 1999/2/1
Y1 - 1999/2/1
N2 - High-risk types of human papillomaviruses (hrHPVs) may be a necessary cause in cervical cancer and in some subtype of anal, vulvar, and penile cancers. Large studies aimed at characterizing hrHPV-associated and non- hrHPV-associated subtypes of anal carcinomas are, however, lacking. We searched for human papillomavirus type 16 and 13 other hrHPVs in tumor tissue by PCR and performed a systematic histological evaluation of specimens from 386 patients with anal cancer (86% invasive; 302 women and 84 men). Cancers in women and homosexual men were more often hrHPV positive (P < 0.01) and located in the anal canal (P ≤ 0.01) than were cancers in heterosexual men. In both women and men, anal canal cancers contained hrHPV clearly more often than did perianal skin cancers, and increasing hrHPV positivity was seen with higher localization in the anal canal. Indeed, 95 and 83% of cancers involving the anal canal in women and menD respectively, were hrHPV positive versus 80 and 28% of perianal skin cancers (P-trend < 0.001). Basaloid feature, adjacent anal intraepithelial neoplasia, poor or absent keratinization, and a predominance of small or medium neoplastic cells were all strongly positively associated with hrHPV status. Like cancer of the uterine cervix, the development of cancer of the anal canal may require infection with hrHPV, whereas a dual etiology of perianal skin cancers bears parallels to vulvar and penile cancers.
AB - High-risk types of human papillomaviruses (hrHPVs) may be a necessary cause in cervical cancer and in some subtype of anal, vulvar, and penile cancers. Large studies aimed at characterizing hrHPV-associated and non- hrHPV-associated subtypes of anal carcinomas are, however, lacking. We searched for human papillomavirus type 16 and 13 other hrHPVs in tumor tissue by PCR and performed a systematic histological evaluation of specimens from 386 patients with anal cancer (86% invasive; 302 women and 84 men). Cancers in women and homosexual men were more often hrHPV positive (P < 0.01) and located in the anal canal (P ≤ 0.01) than were cancers in heterosexual men. In both women and men, anal canal cancers contained hrHPV clearly more often than did perianal skin cancers, and increasing hrHPV positivity was seen with higher localization in the anal canal. Indeed, 95 and 83% of cancers involving the anal canal in women and menD respectively, were hrHPV positive versus 80 and 28% of perianal skin cancers (P-trend < 0.001). Basaloid feature, adjacent anal intraepithelial neoplasia, poor or absent keratinization, and a predominance of small or medium neoplastic cells were all strongly positively associated with hrHPV status. Like cancer of the uterine cervix, the development of cancer of the anal canal may require infection with hrHPV, whereas a dual etiology of perianal skin cancers bears parallels to vulvar and penile cancers.
UR - http://www.scopus.com/inward/record.url?scp=0033082428&partnerID=8YFLogxK
M3 - Journal article
C2 - 9973228
AN - SCOPUS:0033082428
VL - 59
SP - 753
EP - 757
JO - Cancer Research
JF - Cancer Research
SN - 0008-5472
IS - 3
ER -
ID: 259462111